[1] OKAMOTO H,IMAI M,KAMETANI M,et al. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission[J]. J Exp Med,1987,57(4):231-236. [2] KOBAYASHI S,LDE T,SATA M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers[J]. J Hepatol,2001,34:584-586. [3] 刘传苗,张欣欣,陆志檬. 拉米夫定治疗前后乙型肝炎病毒YMDD野毒株和变异株的变化[J]. 肝脏,2004,9(2):73-76. [4] AKARSU M,SENGONUL A. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay[J]. J Gastroenterol Hepatol,2006,21(12):1783-1788. [5] LOK AS,ZOULIM F,LOCARNINI S,et al. Antiviral drug-resistant HBV:standardization of nomenclature and assays and recommendations for management[J]. Hepatology,2007,46:254-265. [6] 季秀玲,沈雪芳,陈宇明,等. 应用实时荧光PCR技术检测HBV YMDD变异[J]. 医学分子生物学杂志,2004,1:279-281. [7] CANE PA,COOK P,RATCLIFFE D,et al. Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatits B virus[J]. Antimicrob Agents Chemother,1999,43:1600-1608. [8] MLMSTROM S,HANNOUN C,M.LINDH. Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR[J]. J Virol Methods,2007,143:147-152. [9] SHI M,WANG RS,YANG ZJ,et a1. Rapid quantitation of lamivudine-resistant mutants in lamivudine treated and untreated patients with chronic hepatitis B virus infection[J]. Clinica Chimica Acta,2006,373:172-175. [10] 霍红,赵书民,蔡雄,等. YMDD自然变异毒株流行病学调查[J]. 肝脏,2006,11(4):232-235. [11] DEGERTEKIN B,HUSSAIN M,TAN J,et al. Sensitivity and accuracy of an updated line probe assay(HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance[J]. J Hepatol,2009,50:42-48. [12] HUSSAIN M,FUNG S,LIBBRECHT E,et al. Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir[J]. J Clin Microbiol,2006,44:1094-1097. |